ACE and COVID-19: The hyperactivity of the angiotensin-converting enzyme (ACE)-Angiotensin (Ang) II- Angiotensin type 1 receptor (AT1) axis of the classical renin–Ang system was shown to contribute to the coagulopathy observed in patients with COVID-19 (74).